Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration

Pitcher A.Emberson J.Lacro R.V.Sleeper L.A.Stylianou M.Mahony L.Pearson G.D.Groenink M.Mulder B.J.Zwinderman A.H.De Backer J.De Paepe A.M.Arbustini E.Erdem G.Jin X.Y.Flather M.D.Mullen M.J.Child A.H.Forteza A.Evangelista A.Chiu H.-H.MEI-HWAN WUSandor G.Bhatt A.B.Creager M.A.Devereux R.B.Loeys B.Forfar J.C.Neubauer S.Watkins H.Boileau C.Jondeau G.Dietz H.C.Baigent C.2021-01-052021-01-0520150002-8703https://www.scopus.com/inward/record.uri?eid=2-s2.0-84929284121&doi=10.1016%2fj.ahj.2015.01.011&partnerID=40&md5=9be0c28f2a7ecf704118ff8331cb03aehttps://scholars.lib.ntu.edu.tw/handle/123456789/538274Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaborationjournal article10.1016/j.ahj.2015.01.011259657072-s2.0-84929284121